Clinical TrialsSearch results
Number of results: 923
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Prevention of food allergy by administration of synbiotics
- Food allergy
- Yanagida Noriyuki
- 2023-01-27
Other
- [M20-466] Moderate to Severe Rheumatoid Arthritis: A Phase 2b, Dose-Ranging, Safety and Efficacy Study of ABBV-154
- Rheumatiod Arthritis
- Yamazaki Hayato
- 2021-08-16
Recruiting
- Open label, multicenter study of gilteritinib in sequential treatment with MEC (Mitoxantrone/ Etoposide/ Cytarabine) in patients with relapsed or refractory FLT3-mutated Acute Myeloid Leukemia
- relapsed/refratory FLT3-mutated acute myeloid leukemia
- Yamauchi Takahiro
- 2020-11-20
Other
- An open-label, long-term study of imeglimin in type 2 diabetic patients with renal impairment
- Type 2 Diabetes
- Yamamoto Koshi
- 2021-12-23
Other
- Randomized phase 3 trial of prophylactic cranial irradiation for patients with extensive small-cell lung cancer
- Extensive small-cell lung cancer patients with no brain metastasis who had a response to platinum-based first-line chemotherapy,
- Yamamoto Group, Grant for Cancer Research, Ministry of Health, Labour, and Welfare
- 2009-03-05
No Longer Recruiting
- Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis (ATIS-NVAF)
- Ischemic Stroke
- Yamagami Hiroshi
- 2019-03-27
Other
- A 5-year study to test BI 655130 in patients with Generalized Pustular Psoriasis who took part in previous studies with BI 655130
- Generalized Pustular Psoriasis (GPP)
- Yamada Nobuko
- 2021-10-20
Other
- Lifestyle intervention for prevention of stroke recurrence in mild stroke
- A Randomized Controlled Trial -
- mild stroke patients with large and small vessel disease
- Yamada Labolatory, School of Health Sciences, Nagoya University
- 2009-04-10
Recruiting
- Study of efficacy and safety of iptacopan in patients with C3 glomerulopathy
- C3G
- Yamada Hiroyuki
- 2021-10-11
Recruiting
- Study to Evaluate the Efficacy and Safety of MAS825 in NLRC4-GOF Patients (MAS NLRC4-GOF)
- NLRC4-GOF
- Yamada Hiroyuki
- 2020-12-16